MAHEPCNSEMahindra EPC Irrigation LimitedMediumNeutral
Announced Tue, 21 Apr · 20:15 IST

Mahindra EPC Irrigation Limited has informed the Exchange about Re-appointment of Mr. Ramesh Ramachandran as a Managing Director and the remuneration payable with effect from 15t September, 2026 for three years and Appointment of Dr. Purvi Mehta and Mr. Balram Singh Yadav as an Additional Non-Executive Independent Directors of the Company, for the term of Five consecutive years with effect from April 21, 2026 to April 20, 2031.

Director Flagged GovernanceManagement Changes View source PDF

MAHEPC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.7%1-day move
₹127.05
prior close
₹124.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-1.2-1.1-1.7-8.7-10.3-9.9-9.4-8.9-8.5-7.0-7.7-5.2-15.8
Up moveDown movePending
AI summary

Mahindra EPC Irrigation Limited held its Board meeting on April 21, 2026, approving multiple matters. Financially, standalone revenue for FY26 was Rs 312 crore (vs Rs 272.67 crore in FY25), with PAT at Rs 12.69 crore (vs Rs 7.21 crore). Consolidated revenue was Rs 312.09 crore with PAT of Rs 9.70 crore. Key board changes include re-appointment of Mr. Ramesh Ramachandran as Managing Director from September 15, 2026 for 3 years, and appointment of Dr. Purvi Mehta and Mr. Balram Singh Yadav as Additional Non-Executive Independent Directors for 5-year terms (April 21, 2026 to April 20, 2031). KMP changes include appointment of Mr. Madhvendra Pratap Singh as Company Secretary (effective May 1, 2026) and cessation of Mr. Ratnakar Nawghare (due to superannuation from April 30, 2026). Auditors re-appointed include B S R & Co. LLP as Statutory Auditors for 5 years. The company also reported material related party transactions with Mahindra & Mahindra Limited that exceeded prescribed limits, requiring SEBI application for contravention. 8,284 equity shares were allotted under ESOS, increasing paid-up capital to 2,79,50,753 shares.

Likely market impact

Strong financial performance with ~58% PAT growth year-on-year; appointment of two highly credentialed independent directors (including a former Gates Foundation executive and Godrej Agrovet MD) should strengthen governance and strategic oversight. SEBI application for RPT contravention indicates governance risk requiring monitoring.